European Addiction Research

Research Report

French Version of the Addiction Severity Index (5th Edition): Validity and Reliability among Swiss Opiate-Dependent Patients

French Validation of the Addiction Severity Index

Krenz S.a · Dieckmann S.a · Favrat B.a · Spagnoli J.b · Leutwyler J.a · Schnyder C.a · Daeppen J.a · Besson J.a

Author affiliations

aDivision of Substance Abuse, University Department of Adult Psychiatry, Lausanne and bResearch Unit, Department of Adult Psychiatry, Lausanne, Switzerland

Related Articles for ""

Eur Addict Res 2004;10:173–179

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Research Report

Published online: September 15, 2004
Issue release date: September 2004

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 5

ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)

For additional information: https://www.karger.com/EAR

Abstract

Objective: The aim of the study was to validate a French adaptation of the 5th version of the Addiction Severity Index (ASI) instrument in a Swiss sample of illicit drug users. Participants and Setting: The participants in the study were 54 French-speaking dependent patients, most of them with opiates as the drug of first choice. Procedure: Analyses of internal consistency (convergent and discriminant validity) and reliability, including measures of test-retest and inter-observer correlations, were conducted. Results: Besides good applicability of the test, the results on composite scores (CSs) indicate comparable results to those obtained in a sample of American opiate-dependent patients. Across the seven dimensions of the ASI, Cronbach’s α ranged from 0.42 to 0.76, test-retest correlations coefficients ranged from 0.48 to 0.98, while for CSs, inter-observer correlations ranged from 0.76 to 0.99. Conclusions: Despite several limitations, the French version of the ASI presents acceptable criteria of applicability, validity and reliability in a sample of drug-dependent patients.

© 2004 S. Karger AG, Basel




Related Articles:


References

  1. McLellan AT, Luborsky L, Woody MD, O’Brien C: An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980;168:26–33.
  2. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Graham G, Pettinatti H, Ageriou M: The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992;9:199–213.
  3. Hodgins D, El-Guebaly M D: More data on the Addiction Severity Index reliability and validity with the mentally ill substance abuser. J Nerv Ment Dis 1992;180:197–201.
  4. McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, O’Brien CP: New data from the Addiction Severity Index – Reliability and validity in three centers. J Nerv Ment Dis 1985;173:412–423.
  5. Hendriks VM, Kaplan CD, Van Limbeek J, Geerlings P: The Addiction Severity Index reliability and validity in a Dutch addict population. J Subst Abuse Treat 1989;6:133–141.
  6. Alterman AL, Brown LS, Zaballero A, McKay J: The interviewer severity ratings and composite scores of the ASI: A further look. Drug Alcohol Depend 1994;34:201–209.
  7. Alterman AL, McDermott, PA, Cook TG, Metzger D, Rutherford MJ, Cacciola JS, Brown LS: New scales to assess change in the Addiction Severity Index for opioids, cocaine and alcohol dependence. Psychol Addict Behav 1998;12:233–246.
    External Resources
  8. McDermott PA, Alterman AI, Brown L, Zaballero A, Snider EC, McKay JR: Construct refinement and confirmation for the Addiction Severity Index. Psychol Assess 1996;8:182–189.
    External Resources
  9. Cacciola J, Griffiths J, McLellan AT: Addiction Severity Index: Instruction Manual, ed 4. Philadelphia, National Institute on Drug Abuse, 1985.
  10. DeJong J, Willems J, Schippers G, Hendriks V: The Addiction Severity Index: Reliability and validity in a Dutch alcoholic population. Int J Addict 1995;30:605–616.
  11. Sandi-Esquivel LE, Avila Corrales K: Validity of the Addiction Severity Index (adapted version) in a Costa Rican population group. Bull Pan Am Health Organ 1990;24:70–76.
  12. Scheurich A, Muller MJ, Wetzel H, Anghelescu I, Klawe C, Ruppe A, Lorch B, Himmerich H, Heidenreich M, Schmid G, Hautzinger M, Szegedi: Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). J Stud Alcohol 2000;61:916–919.
  13. Daeppen JB, Burnand B, Schnyder C, Bonjour M, Pécoud A, Yersin B: Validation of the Addiction Severity Index in French-speaking alcoholic patients. J Stud Alcohol 1996;57:585–590.
  14. Cacciola J, Koppenhaver JM, McKay JR, Alterman AI: Test-retest reliability of the lifetime items on the Addiction Severity Index. Psychol Assess 1999;11:86–93.
    External Resources
  15. American Psychiatric Association: Diagnostic and Statistical Manual, ed 4. Washington, APA, 1980.
  16. Cronbach L: Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297–334.
  17. Zanis DA, McLellan AT, Corse S: Is the Addiction Severity Index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders? Community Ment Health J 1997;33:213–227.
  18. Bergeron J, Landry M, Ishak A, Vaugeois P, Trépanier M: Validation d’un instrument d’évaluation de la gravité des problèmes reliés à la consommation de drogues et d’alcool: L’Indice de Gravité d’une Toxicomanie (IGT). Montréal, Cahiers de recherche du RISQ, 1992.
  19. Leonhard C, Mulvey K, Gastfriend DR, Shwartz M The Addiction Severity Index: A field study of internal consistency and validity. J Subst Abuse Treat 2000;18:129–135.
  20. Carey KB, Coco KM, Correia CJ: Reliability and validity of the Addiction Severity Index among outpatients with severe mental illness. Psychol Assess 1997;4:422–428.
    External Resources
  21. Appleby L, Dyson V, Altman E, Luchins D: Assessing substance use in multiproblem patients: Reliability and validity of the Addiction Severity Index in a mental hospital population. J Nerv Ment Dis 1997;185:159–165.

Article / Publication Details

First-Page Preview
Abstract of Research Report

Published online: September 15, 2004
Issue release date: September 2004

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 5

ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)

For additional information: https://www.karger.com/EAR


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP